Robert Goldstein, M.D.
Robert E Goldstein, M.D.
Name: Robert E Goldstein, M.D.
Cardiovascular Physiology and Pharmacology
Harvard Medical School M.D. magna cum laude 1965
Internal Medicine Residency at Bronx Municipal Hospital Center, Bronx NY 1965-1967
Representative publications, projects, and/or deployments
- Westinghouse Science Talent Search Finalist 1957
- Alpha Omega Alpha Honor Medical Society, elected 1964; Faculty Councilor for USU Chapter 2000-2013
- Cardiology Branch, National Heart, Lung, and Blood Institute, Clinical Associate 1967-1970, Senior Investigator 1971-1980
- John Simon Guggenheim Fellow, St. George's Hospital, London 1974-1975
- Commissioned Corps, US Public Health Service, 1967-1998; CAPT and Senior PHS Officer at USU 1980-1998
- FDA Cardiorenal Advisory Committee, 1982-1985
- Fellow, American College of Physicians 1972-, Master, American College of Physicians, 2002-
- Fellow, American College of Cardiology 1976-, Governor for the US Public Health Service 1981-1984
- Director for Cardiology, Department of Medicine, USU 1984-1996
- Chair, Department of Medicine, USU 1996-2006
- Goldstein, R.E., and Epstein, S.E.: The mechanism of elevated innominate artery pressures in supravalvular aortic stenosis. Circulation 42:23-29, 1970.
- Goldstein, R.E., Redwood, D.R., Rosing, D.R., Beiser, G.D., and Epstein, S.E.: Alterations in the circulatory response to exercise following a meal and their relationship to postprandial angina pectoris. Circulation 44:90-100, 1971.
- Goldstein, R.E., Stinson, E.B., Grehl, T.M., Scherer, J.L., Seningen, R.P., and Epstein, S.E.: Intraoperative coronary collateral function in patients with coronary occlusive disease. Nitroglycerin responsiveness and angiographic correlations. Circulation 49:298-308, 1974.
- Goldstein, R.E.: Coronary vascular responses to vasodilator drugs. Progress in Cardiovasc. Dis. 24:419-436, 1982.
- Goldstein, R.E., Oetgen, W.J., and Tibbits, P.A.: Proarrhythmic effects of antiarrhythmic drugs. Ann. N.Y. Acad. Sci. 427:94-100, 1984.
- Goldstein, R. E., Boccuzzi, S.J., Cruess, D., Nattel, S., the Adverse Experience Committee, and the Multicenter Diltiazem Postinfarction Research Group: Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. Circulation 83:52-60, 1991.
- Goldstein, R.E., Boccuzzi, S.J., Cruess, D., and the Multicenter Diltiazem Postinfarction Trial Research Group: Prognosis after hospitalization for acute myocardial infarction not accompanied by typical ischemic chest pain. Am. J. Med. 99:123-131, 1995.
- Goldstein R.E., Haigney M.C., Krone R.J., McNitt S., Zareba W, and Moss A.J. Differing effects of cardiac resynchronization therapy on long-term mortality in patient subgroups of MADIT-CRT defined by baseline conduction and one-year post-treatment left ventricular remodeling. Heart Rhythm 2013;10:366-373.
- Klein M.G., Shou M., Stohlman J., Haigney M., Tidwell R.R., Goldstein R.E., Flagg, T.P., and Haigney, M.C. Role of Suppression of the Inward Rectifier Current (IK1) on Terminal Action Potential Repolarization in the Failing Heart. Heart Rhythm 2017;14: 1217-1223.